Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 3 out of 23 pages
Exam (elaborations)

NR 293 Pharmacology Final Exam | Actual Exam Questions & Verified Answers with Detailed Rationales | 2026–2027 Updated Chamberlain Pharmacology | Grade A

Document preview thumbnail
Preview 3 out of 23 pages

This NR 293 Pharmacology Final Exam study guide is a complete resource for nursing students enrolled in Chamberlain University’s NR 293 Pharmacology course. It features actual exam-style questions with verified answers and detailed rationales, aligned with the 2026–2027 updated Chamberlain pharmacology curriculum and the BSN exam format. The guide covers all high-yield pharmacology topics tested on the final exam, including major drug classifications, pharmacokinetics, pharmacodynamics, therapeutic effects, adverse drug reactions, contraindications, medication safety, and nursing responsibilities during medication administration. Each question includes a detailed rationale to reinforce understanding and strengthen clinical reasoning skills. Ideal for BSN and RN nursing students, this study guide provides structured exam preparation and focused review of essential pharmacology concepts. By emphasizing verified answers and exam-aligned practice questions, it helps improve knowledge retention, strengthen exam readiness, and build confidence for the NR 293 Pharmacology Final Exam.

Content preview

1|Page




NR 293 Pharmacology Final Exam | Actual Exam

Questions & Verified Answers with Detailed

Rationales | 2026–2027 Updated Chamberlain

Pharmacology | Grade A




Question 1

Centrally acting alpha-2 receptor agonists, such as clonidine and methyldopa, lower

blood pressure by:

A. Blocking alpha-1 receptors on blood vessels

B. Stimulating alpha-2 receptors in the brain, decreasing sympathetic outflow

C. Blocking beta-1 receptors in the heart

D. Inhibiting angiotensin-converting enzyme

CORRECT ANSWER: B. Stimulating alpha-2 receptors in the brain, decreasing

sympathetic outflow

Rationale: Centrally acting alpha-2 agonists stimulate alpha-2-adrenergic receptors in

,2|Page


the brainstem, which reduces sympathetic nervous system outflow, leading to

decreased peripheral vascular resistance and lower blood pressure.

Question 2

Clonidine has a unique off-label use in the management of:

A. Hypertension during pregnancy

B. Withdrawal symptoms in opioid-dependent persons

C. Heart failure

D. Angina

CORRECT ANSWER: B. Withdrawal symptoms in opioid-dependent persons

Rationale: Clonidine is sometimes used to manage withdrawal symptoms in opioid-

dependent individuals by reducing sympathetic outflow and alleviating symptoms like

anxiety, agitation, and tachycardia.

Question 3

Peripherally acting alpha-1 receptor blockers (e.g., doxazosin, prazosin, terazosin) are

known by the suffix "-azosin." A serious adverse effect associated with the first dose

of these medications is:

A. Hyperkalemia

B. First-dose hypotension and syncope

C. Bronchospasm

, 3|Page


D. Tachyphylaxis

CORRECT ANSWER: B. First-dose hypotension and syncope

Rationale: Alpha-1 blockers can cause significant vasodilation, leading to marked

orthostatic hypotension, especially with the first dose. Patients should be instructed to

take the first dose at bedtime to minimize the risk of falls from dizziness and syncope.

Question 4

Beta-blockers (ending in "-olol") lower blood pressure primarily by:

A. Causing direct vasodilation

B. Reducing heart rate and cardiac output

C. Blocking angiotensin II receptors

D. Increasing sodium and water excretion

CORRECT ANSWER: B. Reducing heart rate and cardiac output

Rationale: Beta-blockers work by blocking beta-1 adrenergic receptors in the heart,

which decreases heart rate, myocardial contractility, and cardiac output, thereby

lowering blood pressure. They also reduce renin secretion.

Question 5

Carvedilol and labetalol are unique beta-blockers because they also have:

A. Alpha-1 blocking activity, causing vasodilation

B. Central alpha-2 agonist activity

Document information

Uploaded on
March 13, 2026
Number of pages
23
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers
$13.49

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
DrEmma
4.2
(9)
Sold
67
Followers
2
Items
1559
Last sold
16 hours ago




Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions